SpineThera

About:

SpineThera is a pharmaceutical company that develops novel, sustained-release, and injectable drugs to treat pain.

Twitter/X: spinethera

Top Investors: U.S. Department of Defense, United States Army

Description:

SpineThera develops novel, sustained-release, injectable drugs to treat pain; offering patients and physicians alternatives that reduce risk, improve outcomes, and manage overall treatment costs in markets with few or no approved drugs. It was founded in 2012 and is headquartered in Plymouth, Minnesota.

Total Funding Amount:

$30.5M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Plymouth, Minnesota, United States

Founded Date:

2012-01-01

Contact Email:

info(AT)spinethera.com

Founders:

Jeff Missling

Number of Employees:

1-10

Last Funding Date:

2022-04-26

IPO Status:

Private

Industries: